Overview

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
NETU-10-29 is a clinical study assessing safety of netupitant and palonosetron, two antiemetic drugs, both given with oral dexamethasone. The objective of the study is to evaluate if netupitant and palonosetron are safe when administered to prevent nausea and vomiting after administration of repeated cycles of chemotherapy.
Phase:
Phase 3
Details
Lead Sponsor:
Helsinn Healthcare SA
Collaborator:
Parexel
Treatments:
Aprepitant
BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate
Fosaprepitant
Palonosetron